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Introduction: Adult-onset Still disease (AOSD) is a rare systemic inﬂammatory disease of
unknown cause. Its symptoms usually include persistent fever, fugitive salmon-colored
rash, arthritis, sore throat (not speciﬁc), but it may also lead to internal organs' involvement,
which presents with enlargement of the liver and spleen, swollen lymph nodes, carditis or
pleuritis – potentially life-threatening complications. In rare cases, AOSD can cause aseptic
meningitis or/and encephalitis.
Case presentation: We report a case of 31-year-old male patient, who was referred to
neurological department for extending diagnostics of frontal lobes lesions with involvement
of adjacent meninges. Abnormalities have been revealed in brain MRI, which was performed
due to persistent headaches, visual disturbances, fever, fatigue and cognitive decline. Wide
differential diagnosis was performed including laboratory ﬁndings, contrast enhanced MRI,
MR spectroscopy, ﬂow cytometry and ﬁnally brain biopsy to exclude neoplastic or infectious
origin. Final diagnosis of autoimmune meningoencephalitis in adult-onset Still disease has
been made.
Conclusion: Adult-onset Still disease is a rare cause of inﬂammatory changes in central
nervous system, which if diagnosed, may be treated successfully with steroids (commonly
available agent), intravenous immunoglobulins or more speciﬁc immunomodulating regi-
ments.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
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Meningoencephalitis is a condition that simultaneously
involves both meninges and brain parenchyma [1]. Clinical
manifestation and severity depend on several factors, such as
etiology, lesion's location (diffuse vs focal), potential compli-* Corresponding author at: 1st Department of Neurology, Institute of Ps
E-mail address: jarosz@ipin.edu.pl (H. Sienkiewicz-Jarosz).
http://dx.doi.org/10.1016/j.pjnns.2017.06.006
0028-3843/© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Ncations etc. Prodrome symptoms usually include fever,
headache, nausea and vomiting, lethargy, fatigue, and usually
they can be followed by altered mental status, behavioral and
personality changes, hypersomnolence, language difﬁculties,
focal neurological deﬁcits (e.g., hemiparesis, cranial nerves
palsies). If not treated, may lead to seizures, increased
intracranial pressure, coma and death. Patient's history mayychiatry and Neurology, Sobieskiego Str. 9, 02-957 Warsaw, Poland.
eurological Society.
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animal bites, comorbidities including coexisting systemic
autoimmune disorder, exposure to certain chemical, toxic or
intoxicating substances or drugs etc.). Physical examination is
also of great importance (e.g., rash, lymphadenopathy,
hepatosplenomegaly, herpetic skin lesions) [2].
Differential diagnosis is complex especially if there is no
history of preceding protozoans, viral or bacterial infection or
travel health problems. But even the obvious infectious
etiology requires infectious agent identiﬁcation with metic-
ulous serological testing, lesions smear, blood or CSF
cultures [2].
Autoimmune encephalitis is a complex disease related to
diverse immunologic response to coexisting neoplastic or non-
neoplastic condition, or resulting from central nervous system
vasculitis (primary or secondary). Autoimmune encephalitis
can be suspected if there is evidence of serologic autoimmu-
nity and intrathecal inﬂammation in the cerebrospinal ﬂuid
sometimes combined with diffused brain lesions [3].
As autoimmune causes of encephalitis are less common,
diagnosis is usually made by an exclusion of other, more
probable causative factors (infectious, toxic, metabolic, vascu-
lar or structural damage). Therefore, while diagnosing a
patient with symptoms suggestive of meningoencephalitis
several laboratory, neuroimaging and serological investiga-
tions must be carried out. Apart from typical laboratory
evaluation (including complete blood counts, erythrocyte
sedimentation rate, C-reactive protein, renal, liver and thyroid
function, vitamin B complex deﬁciency), the markers of
underlying systemic autoimmune disease should be obtained
(e.g. anti-nuclear antibodies [ANA], anti-neutrophil cyto-
plasmic antibodies [ANCA], lupus anticoagulant [LA]). Cere-
brospinal ﬂuid analysis is crucial for exclusion of infectious
and neoplastic background, moreover it can provide an
evidence of intrathecal inﬂammation [4–6]. Magnetic reso-
nance imaging is the method of choice for identiﬁcation of
vascular, demyelinating or neoplastic lesion. Due to increasing
number of patient with antibodies-speciﬁc encephalopathies,
the presence of some autoantibodies should be assessed (e.g.
anti-NMDA receptor, anti-CASPR2 or anti-LGI1) [3–6].
Autoimmune encephalitis can produce a wide range of
symptoms, that may mimic other neurological or psychiatric
disorders, (e.g. limb or cranial nerve palsies, ataxia, involun-
tary movements, cognitive impairment, agitation, hallucina-
tions or delirium, severe anxiety). Immunomodulating
therapy may give improvement and it may include steroids,
plasmapheresis or intravenous immunoglobulin (IVIG) [5,6]
Removal of triggering factor (if present, such as coexisting
neoplasm) is also effective [5,6]. In case of known cause that
triggers immune response guided treatment methods may be
required [5,6].
2. Case report
31-Year-old male patient was admitted to the neurological
department due to frontal lobes lesions involving meninges of
unknown etiology. Abnormalities have been revealed in brain
MRI, which was performed due to persistent headaches, visual
disturbance, fever, sleepiness, cognitive decline and weightloss. Previously the patient was hospitalized in other neuro-
logical ward and infectious disease department, where
tuberculosis and bacterial meningitis have been excluded.
As a 6-month-old baby the patient was diagnosed with
phenylketonuria. He also reported that he had been treated
for a long time because of Still disease diagnosis, but he
stopped this treatment because long remission.
At admission the neurological examination was normal,
apart for slowness of movements and apathy.
Contrast-enhanced MRI showed bilateral frontal lobes
abnormalities, including poorly marginated cortical and
subcortical hyperintensities on T2 weighted and FLAIR images
with lobes swelling, little mass effect and absence of
parenchymal enhancement (Fig. 1a and b). Abnormal menin-
geal thickening and enhancement especially prominent in
both frontal regions including anterior part of falx cerebri was
detected on gadolinium-enhanced T1-weighted image (Fig. 1c
and d). Brain MRI was assessed by a neuroradiologist as non-
speciﬁc localized hypertrophic pachymeningitis with frontal
brain edema. Lesions location was not typical for tuberculosis.
Basic laboratory ﬁndings (such as complete blood counts,
liver and renal testing, electrolytes, coagulation, CRP, serum
protein electrophoresis) were normal apart from increased
sedimentation rate (16 mm/h). HBV, HCV and HIV1/HIV2
antibodies were negative. Lupus antigen was present, unlike
anticardiolipin (aCL) antibodies, which were absent. Serum
rheumatoid factor and anti-nuclear antibodies were not
performed as they were negative in several previous measure-
ments. Ferritin was normal (75.1 ng/ml with normal range of
22–322 ng/ml). The serum level of glycosylated ferritin was not
measured as the test was not available in author's research
center.
Lumbar puncture was performed. General CSF analysis
exhibited normal results except for slightly increased number
of white cells (6 cells in mm3 with normal range of 0–5 cells in
mm3, 82% of lymphocytes). The cerebrospinal ﬂuid immuno-
globulin index revealed several abnormalities: IgG CSF
6.70 mg/dl (normal range: 0.63–3.35), IgG CSF/protein CSF
19.1% (normal range: 0.0–12.0), IgG Index 1.11 (normal range:
0.00–0.70), IgG daily synthesis 3.11 mg/24 h (normal range:
0.00–3.30) and local IgG synthesis 2.78 mg/dl (normal range:
<0.01). Oligoclonal bands were also present. CSF cytologic
examination did not reveal any abnormal (neoplastic) cells.
Both serum and CSF testing for HSV DNA were negative.
Serum Toxoplasma gondi antibodies were positive (which is
probably an accidental ﬁnding as seroprevalence of Toxoplas-
ma gondi antibodies in a healthy population is 20–24%) [7,8].
CSF Toxoplasma gondi antibodies were negative (0 IU/ml with
normal range of <4 IU/ml). Serum and CSF ACE levels were
normal.
The patient's case was consulted with infectious disease
specialist, who advised anti-viral therapy – acyclovir was
administered intravenously, but clinical improvement was not
achieved.
To help identify a nature of brain lesions MR spectroscopy
was performed (not shown). The conclusion suggested active
neoplastic or inﬂammatory process with decrease NAA/Cr
ratio and increased Cho/Cr ratio.
During second hospitalization – a month later, contrast
enhanced MRI revealed further progression of frontal lesions
Fig. 1 – Baseline neuroimaging of patient with adult-onset Still's disease. (a and b) Axial FLAIR images showing diffuse
bilateral frontal hyperintensities with swelling and little mass effect. (c and d) Axial gadolinium enhanced T1 weighted
images demonstrate relatively thick pachymeningeal enhancement of the anterior cranial fossa and in the dural reflections
of the anterior falx with a hypointense frontal edema.
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frontal lobes. Flow cytometry excluded the presence of
lymphoma cells in cerebro-spinal ﬂuid. The patient was then
transferred to the Department of Neurosurgery and under-
went brain biopsy. The histopathological analysis of biopsy
material revealed thicken proliferating dura mater with
diffuse desmoplasia (Fig. 2a), inﬂammatory inﬁltration and
granular vasculitis (Fig. 2b).Fig. 2 – Stereotactic biopsy specimen, hematoxylin-eosin stainin
(desmoplasia), (b) mononuclear cells inflammatory infiltration aDuring a visit in out-patient clinic a month later the patient
revealed that he had been treated due to adult-onset Still
disease for nearly 5 years and the treatment was completed 4
months before neurologic symptoms onset. The diagnosis was
made 6 years earlier when the patient suffered from arthralgia,
high fevers, salmon-colored rash over lower extremities,
abdominal lymphadenopathy and splenomegaly. Leukocyto-
sis with granulocyte predominance was also present. Theg. (a) The growth of fibrous or connective tissue
nd granular vasculitis.
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followed by oral steroids. Due to poor symptoms control
methotrexate was added with good outcome (clinical and
laboratory remission was achieved).
Taking all the above into consideration, after exclusion of
infectious, other systemic and neoplastic cause, the suspicion
of autoimmune meningitis and encephalitis in adult-onset
Still's disease was raised and immunosuppressive treatment
had been started. Methylprednisone i.v. was introduced as the
ﬁrst-line therapy and followed by oral prednisone. Contrast
brain MRI performed a month later, showed signiﬁcant
remission of inﬂammatory lesion within brain tissue and
meninges (Fig. 3). The patient has been referred to rheumatol-
ogy ward, where autoimmune vasculitis has been suspected.
Currently, the patient is treated with subcutaneous
methotrexate 25 mg/week, and oral prednisone 35 mg daily.
He reports further regression of his symptoms.
3. Discussion
Still's disease was ﬁrst described in children in 1897 by George
Frederic Still, an English physician [9]. Cases of adults with
similar clinical presentation were later described by Eric
Bywaters in 1971 [10]. Adult onset Still's disease is a rareFig. 3 – Follow-up neuroimaging. FLAIR (a and b), and contrast e
volume of the frontal lobes lesions, resolution of the frontal edem
and dural thickening is decreased compared with the baseline icondition with an estimated prevalence of 1 person per 100,000
people, what make its potential neurological complications
even rarer [11]. The diagnosis of adult-onset Still's disease is
made via exclusion, when typical symptoms are present and
other potential causes are absent. Preliminary criteria for
classiﬁcation of adult Still's disease were proposed by
Yamaguchi et al. in 1992 (Table 1) [12].
These criteria were modiﬁed in 2001 by Fautrel et al., who
emphasized the value of ferritin and glycosylated ferritin level
in diagnosing adult onset Still's disease (Table 2) [13].
Presented patient fulﬁlled both Yamaguchi and Fautrel criteria
when he was diagnosed with AOSD [12,13].
Systemic involvement is frequent and it includes poten-
tially life-threatening conditions, such as pericarditis, endo-
carditis or/and myocarditis, pericardial tamponade, pleuritis,
pneumonitis, acute respiratory distress syndrome (ARDS),
alveolar hemorrhage, multiorgan failure, fulminant liver
failure, disseminated intravascular coagulation (DIC syn-
drome), thrombotic microangiopathy, glomerulopathy [14].
Neurological complications are rare and occur in 7–12% of
patients with adult onset Still's disease [15,16]. In the course of
disease several neurological syndromes have been reported,
such as cranial nerve palsies, seizures, aseptic meningoen-
cephalitis, posterior reversible encephalopathy syndrome,
Miller-Fisher syndrome, and peripheral neuropathy [17–21].nhanced T1-weighted sequences (c and d) revealed reduced
a and the mass effect, overall enhanced T1-weighted signal
mage.
Table 1 – Adult onset Still's disease diagnostic criteria by
Yamaguchi [12].
Major criteria
Fever ≥39 8C for more than a week
Arthralgia for more than 2 weeks
Typical rash
Leucocytosis ≥10,000/ml (with >80% of neutrophiles)
Minor criteria
Sore throat
Lymphadenopathy and/or splenomegaly
Liver disfunction (increased AST, ALT or LDH)
Negative ANA, RF
Excluding criteria
Infection, sepsis, infectious mononucleosis
Neoplasm (lymphoma in particular)
Other reumathic disease (such as granular vasculitis and
rheumatoid vasculitis)
Table 2 – Adult onset Still's disease diagnostic criteria by
Fautrel [13].
Major criteria
Fever ≥39 8C
Acute arthralgia
Sore throat
Fugitive erythematous rash
Granulocytosis >80%
Glycosylated ferritin ≤20%.
Minor criteria
Fugitive salmon-colored rash
Leukocytosis ≥10,000/ml
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affecting brain (e.g. systemic lupus erythematosus, Susac's
syndrome, Whipple's disease, Sjögren's syndrome, Behçet's
disease). A link between immune dysfunction and brain
involvement is complex and may include cerebral vascular
changes or presence of antibodies targeting synaptic proteins
[22]. Our patient fulﬁlled AOSD diagnostic criteria and for
many years had been treated successfully with immunosup-
pressive agents. Laboratory remission has been achieved,
which explains normal serum laboratory results. CSF exam in
the patient showed only small pleocytosis. We did not
observed neutrophilic predominance, which was described
in other case reports considering aseptic meningitis in adult
onset Still's disease [23,24].
Interestingly, lupus anticoagulant (LA) was found – the
positive result for LA does not have to put in question Still's
disease diagnosis. Lupus anticoagulant (LA) is a heterogeneous
group of antibodies, which is usually present in patients with
systemic lupus erythromatosus, however at least 50% of
people with lupus anticoagulants do not present with this
condition [25]. Moreover the prevalence of LA in the general
population is about 10% [26]. It may be also present in other
connective tissue disorders, malignancies and infections or
may be drug-induced [27]. Systemic Lupus International
Collaborating Clinics Classiﬁcation Criteria for Systemic Lupus
Erythematosus were also not met, neither during current
hospitalization nor retrospectively [28].Establishment of the diagnosis of Still's disease needs
careful exclusion of other possible etiology of aseptic
meningoencephalitis. In our patient CNS infectious dis-
eases have been excluded, including tuberculosis, Borrelia
burgdorferi, syphilis, CNS fugal infection, neurocysticerco-
sis, HSV infection. Other immune disorders have been also
considered (e.g. Wegener granulomatosis, rheumatoid
arthritis, sarcoidosis, Sjögren disease, giant cell arteritis)
with negative results. Tumor (including lymphoma) or
metastases were excluded. Brain biopsy conﬁrmed the
presence of chronic inﬂammatory process within brain
tissue and meninges.
Data on neuropathological ﬁndings in adult onset Still's
disease is scarce. In single case reports of adult-onset Still's
disease with central nervous system involvement (CNS) brain
pathological examination showed demyelinating lesions
[29,30]. In other case report brain biopsy revealed reactive
inﬂammatory injury with extensive Alzheimer type 2 cells and
microvascular changes [31]. In several other reports multisys-
tem involvement, including CNS, was reported as a result of
macrophage activation syndrome due to uncontrolled prolif-
eration of T lymphocytes and well-differentiated macrophages
[32,33]. Presented patient met the Criteria for autoantibody
negative but probable autoimmune encephalitis proposed by
Graus et al. [34]: the progression of symptoms was rapid and
had begun shortly after discontinuation of immunosuppres-
sive treatment, well deﬁned syndromes of autoimmune
encephalitis were excluded, patient had MRI abnormalities,
small CSF pleocytosis and positive brain biopsy showing
inﬂammatory inﬁltrates, the other reasonable alternative
causes were excluded.
All the above, together with good response to steroids made
Still's disease a probable cause of brain lesions detected in
brain MRI in our patient.
The neurological complications of Still disease are ex-
tremely rare, so there is no established treatment recommen-
dations, although methotrexate and steroids are preferably
used drugs.
4. Conclusion
Adult onset Still's disease is a rare systemic inﬂammatory
disease of unknown cause with well-deﬁned systemic symp-
toms and potentially life-threatening complications. Central
nervous system is rarely affected by inﬂammatory process in
Still's disease. Nevertheless in case of neurological deﬁcits
appearance and brain MRI abnormalities in patient with Still's
disease underlying autoimmunological process should be
considered.
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